Source:http://linkedlifedata.com/resource/pubmed/id/16876769
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1
|
pubmed:dateCreated |
2006-9-18
|
pubmed:abstractText |
This study examined the effects of chronic corticosterone (32 mg/kg/day, s.c., 21 days) on brain-derived neurotrophic factor (BDNF) mRNA and protein in the frontal cortex and hippocampus of the rat. Because evidence suggests that BDNF is an important determinant of the function of the 5-hydroxytryptamine (5-HT) system, we also quantified tissue levels of 5-HT and its major metabolite, 5-hydroxyindoleacetic acid (5-HIAA), to investigate if changes in BDNF mRNA and protein paralleled changes in the 5-HT system. Corticosterone modestly decreased BDNF protein (-16.6%) in whole hippocampus and BDNF mRNA (-19%) in the CA3 area. In contrast, BDNF mRNA and protein in the frontal cortex were unchanged. In both the frontal cortex and hippocampus, tissue levels of 5-HT and 5-HIAA were increased and decreased, respectively. Combined, these data suggests that the effects of corticosterone on the BDNF system are not linked to the effects on the 5-HT systems. However, our findings do suggest that chronic corticosterone impairs hippocampal BDNF function, a finding with potential relevance for the hippocampal atrophy reported in major depression. Additionally, as inferred from the alterations in tissue levels of 5-HT and 5-HIAA, chronic corticosterone may influence the function of the 5-HT system.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Brain-Derived Neurotrophic Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Corticosterone,
http://linkedlifedata.com/resource/pubmed/chemical/Hydroxyindoleacetic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Serotonin
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0006-8993
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
19
|
pubmed:volume |
1110
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
221-5
|
pubmed:meshHeading |
pubmed-meshheading:16876769-Animals,
pubmed-meshheading:16876769-Autoradiography,
pubmed-meshheading:16876769-Brain Chemistry,
pubmed-meshheading:16876769-Brain-Derived Neurotrophic Factor,
pubmed-meshheading:16876769-Corticosterone,
pubmed-meshheading:16876769-Drug Administration Schedule,
pubmed-meshheading:16876769-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:16876769-Frontal Lobe,
pubmed-meshheading:16876769-Gene Expression,
pubmed-meshheading:16876769-Hippocampus,
pubmed-meshheading:16876769-Hydroxyindoleacetic Acid,
pubmed-meshheading:16876769-In Situ Hybridization,
pubmed-meshheading:16876769-Male,
pubmed-meshheading:16876769-RNA, Messenger,
pubmed-meshheading:16876769-Rats,
pubmed-meshheading:16876769-Rats, Wistar,
pubmed-meshheading:16876769-Serotonin
|
pubmed:year |
2006
|
pubmed:articleTitle |
Chronic corticosterone decreases brain-derived neurotrophic factor (BDNF) mRNA and protein in the hippocampus, but not in the frontal cortex, of the rat.
|
pubmed:affiliation |
Department of In Vivo Pharmacology, NeuroSearch A/S, Pederstrupvej 93, Ballerup, Denmark. jpj@neurosearch.dk
|
pubmed:publicationType |
Journal Article,
Comparative Study
|